Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma

Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients

Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA
Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients ( Prof Federico Innocenti - University of North Carolina, Chapel Hill, USA )
4 Nov 2020

The ENA virtual meeting 2020

Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
The ENA virtual meeting 2020 ( Dr. Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
4 Nov 2020

Development of novel inhibitors of KRASG12C

Dr Kevan Shokat - University of California San Francisco, San Francisco, USA
Development of novel inhibitors of KRASG12C ( Dr Kevan Shokat - University of California San Francisco, San Francisco, USA )
4 Nov 2020

Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy

Dr Julius Strauss - National Institutes of Health, Bethseda, USA
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy ( Dr Julius Strauss - National Institutes of Health, Bethseda, USA )
4 Nov 2020

Biomarker-driven clinical trials: promises and pitfalls

Dr Renzo Canetta - Independent consultant
Biomarker-driven clinical trials: promises and pitfalls ( Dr Renzo Canetta - Independent consultant )
29 Oct 2020

Key themes, highlights and importance of this year's IBCD 2020 meeting

Dr Roberto Salgado - Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium
Key themes, highlights and importance of this year's IBCD 2020 meeting ( Dr Roberto Salgado - Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium )
29 Oct 2020

How current assay approval policies are leading to unintended imprecision medicine

Dr Roberto Salgado - Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium
How current assay approval policies are leading to unintended imprecision medicine ( Dr Roberto Salgado - Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium )
29 Oct 2020

OncoAlert and ecancer weekly roundup for October 19-26, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 19-26, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
28 Oct 2020

OncoAlert and ecancer weekly roundup for October 12 - 18, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 12 - 18, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
23 Oct 2020

OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for October 5th - October 11th, 2020 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
12 Oct 2020

Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer

Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer ( Dr Paolo Nuciforo - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
6 Oct 2020

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation